Publications by authors named "M Nardin"

Background And Aim: Diabetes has been shown in last decades to be associated with a significantly higher mortality among patients with ST-segment elevation myocardial infarction (STEMI) treated with primary PCI (PPCI). Therefore, the aim of current study was to evaluate the impact of diabetes on times delays, reperfusion and mortality in a contemporary STEMI population undergoing PPCI, including treatment during the COVID pandemic.

Methods And Results: The ISACS-STEMI COVID-19 is a large-scale retrospective multicenter registry involving PPCI centers from Europe, Latin America, South-East Asia and North-Africa, including patients treated from 1st of March until June 30, 2019 and 2020.

View Article and Find Full Text PDF

Purposes: Evaluate the changes in quality of life (QoL) in patients affected by tertiary hyperparathyroidism (THPT) after surgical treatment using the Parathyroidectomy Assessment of Symptoms (PAS) and Short Form-36 (SF-36) questionnaires.

Methods: Single centre longitudinal retrospective, single-institution analysis of 34 patients with THPT and submitted to parathyroidectomy between 2015 and 2021. The PAS and SF-36 questionnaires were administered before surgery and 24 months after discharge.

View Article and Find Full Text PDF

Background: Despite the improvements in drug eluting stents (DES) technology, suboptimal results have been observed in certain higher-risk subsets of patients, as in diabetes mellitus (DM). Drug-coated balloons (DCB) could represent an alternative to DES in complex populations and anatomies, as in DM.

Aims: The present meta-analysis aimed at assessing the role of DCBs in patients with diabetes mellitus.

View Article and Find Full Text PDF

Background: Hypertension is the most prevalent cardiovascular risk factor, with several detrimental effects on the cardiovascular system. Contrasting results have been reported so far on its prognostic role in patients admitted for ST-segment elevation myocardial infarction (STEMI). Therefore, we investigated the impact of hypertension on short-term mortality in a large multicenter contemporary registry of STEMI patients, including patients treated during COVID-19 pandemic.

View Article and Find Full Text PDF
Article Synopsis
  • - MASLD is a serious health issue linked to obesity, metabolic syndrome, and type 2 diabetes, involving fat buildup in the liver unrelated to alcohol use, making it a major cause of chronic liver disease worldwide.
  • - This condition raises the risk of severe cardiovascular events due to factors like oxidative stress, insulin resistance, and inflammation, which can lead to heart issues.
  • - Managing MASLD is essential for liver and heart health, with lifestyle changes like diet and exercise being key, alongside medications for diabetes; ongoing research is exploring new treatment options.
View Article and Find Full Text PDF